STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

I-Mab to Release Q3 2024 Financial Results on November 14, 2024

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags

I-Mab (NASDAQ: IMAB) announced it will release its Q3 2024 financial results on November 14, 2024, before the US market opens. The company will not hold a conference call for Q3 results but plans to host an investor update call with its full-year 2024 results, where it will discuss its clinical pipeline, corporate strategy, and objectives. Financial results and related information will be available on the company's website.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

ROCKVILLE, Md., Oct. 31, 2024 /PRNewswire/ -- I-Mab (NASDAQ: IMAB) (the "Company"), a US-based, global biotech company, exclusively focused on the development of highly differentiated immunotherapies for the treatment of cancer, today announced that it plans to release financial results for the third quarter ended September 30, 2024, on Thursday, November 14, 2024, pre-market Eastern Time.

The Company will not host a conference call to discuss its third quarter 2024 financial results. The Company intends to host an investor update call in conjunction with its 2024 full-year financial results to discuss its clinical pipeline, corporate strategy, and objectives. Information about financial results, conference calls, webcasts, and other information is posted on the Company's website.

About I-Mab

I-Mab (NASDAQ: IMAB) is a US-based, global biotech company, exclusively focused on the development of highly differentiated immunotherapies for the treatment of cancer.

I-Mab has established operations in Rockville, Maryland, and Short Hills, New Jersey. For more information, please visit https://www.i-mabbiopharma.com and follow us on LinkedIn and X.

I-Mab Investor & Media Contacts
Tyler Ehler
Senior Director, Investor Relations
IR@imabbio.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/i-mab-to-release-q3-2024-financial-results-on-november-14-2024-302292364.html

SOURCE I-Mab Biopharma

FAQ

When will I-Mab (IMAB) release its Q3 2024 financial results?

I-Mab will release its Q3 2024 financial results on Thursday, November 14, 2024, before the US market opens (pre-market Eastern Time).

Will I-Mab (IMAB) host a Q3 2024 earnings call?

No, I-Mab will not host a conference call to discuss Q3 2024 financial results. However, the company plans to host an investor update call with its full-year 2024 results.

What will I-Mab (IMAB) discuss in its upcoming full-year 2024 investor update call?

I-Mab plans to discuss its clinical pipeline, corporate strategy, and objectives during the full-year 2024 investor update call.
I-Mab

NASDAQ:IMAB

IMAB Rankings

IMAB Latest News

IMAB Latest SEC Filings

IMAB Stock Data

533.68M
78.65M
21.43%
20%
2.43%
Biotechnology
Healthcare
Link
United States
Rockville